Anticancer Plants: Clinical Trials and Nanotechnology

Volume 3

Nonfiction, Science & Nature, Science, Biological Sciences, Biochemistry, Botany
Cover of the book Anticancer Plants: Clinical Trials and Nanotechnology by , Springer Singapore
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9789811082160
Publisher: Springer Singapore Publication: July 3, 2018
Imprint: Springer Language: English
Author:
ISBN: 9789811082160
Publisher: Springer Singapore
Publication: July 3, 2018
Imprint: Springer
Language: English

Cancer is one of the leading causes of death in human beings. Though several synthetic medicines are used to treat cancer, they are largely inefficient and unsafe. In contrast, plants, which have been used for medicinal purposes since time immemorial, have proved to be useful in fighting cancer, with natural compounds from plants and their derivatives offering safe and effective treatment and management for several types of cancer.

Plants such as Catharanthus roseus, Podophyllum peltatum, Taxus brevifolia, Camptotheca acuminate, Andrographis paniculata, Crateva nurvala, Croton tonkinensis, Oplopanax horridus etc., are important source of chemotherapeutic compounds. These plants have proven their value in the treatment of cancer and various other infectious diseases, and several common anticancer compounds such as taxol, *podophyllotoxins, camptothecin, vinblastine, vincristine, homoharringtonine *etc. have been isolated and purified from these medicinal plants.

Unfortunately, many of these anticancer plants have become endangered due to ruthless and irresponsible harvesting practices. Hence, there is a need to conserve these species and to propagate them on a large scale using plant tissue culture. Alternatively, plant cell tissue and organ culture biotechnology could be adopted to produce these anticancer compounds without the need for cultivation. A better grasp and continuing exploration of these isolated molecules and products could provide a powerful alternative means of reducing cancer risk.

“Anticancer Plants: Volume 3, Clinical Trials and Nanotechnology” provides a timely review of concepts and experimental data on the application of anticancer plants and their compounds in clinical trials, and on the use of nanotechnology in cancer therapy.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Cancer is one of the leading causes of death in human beings. Though several synthetic medicines are used to treat cancer, they are largely inefficient and unsafe. In contrast, plants, which have been used for medicinal purposes since time immemorial, have proved to be useful in fighting cancer, with natural compounds from plants and their derivatives offering safe and effective treatment and management for several types of cancer.

Plants such as Catharanthus roseus, Podophyllum peltatum, Taxus brevifolia, Camptotheca acuminate, Andrographis paniculata, Crateva nurvala, Croton tonkinensis, Oplopanax horridus etc., are important source of chemotherapeutic compounds. These plants have proven their value in the treatment of cancer and various other infectious diseases, and several common anticancer compounds such as taxol, *podophyllotoxins, camptothecin, vinblastine, vincristine, homoharringtonine *etc. have been isolated and purified from these medicinal plants.

Unfortunately, many of these anticancer plants have become endangered due to ruthless and irresponsible harvesting practices. Hence, there is a need to conserve these species and to propagate them on a large scale using plant tissue culture. Alternatively, plant cell tissue and organ culture biotechnology could be adopted to produce these anticancer compounds without the need for cultivation. A better grasp and continuing exploration of these isolated molecules and products could provide a powerful alternative means of reducing cancer risk.

“Anticancer Plants: Volume 3, Clinical Trials and Nanotechnology” provides a timely review of concepts and experimental data on the application of anticancer plants and their compounds in clinical trials, and on the use of nanotechnology in cancer therapy.

More books from Springer Singapore

Cover of the book Disruptive Technologies for the Militaries and Security by
Cover of the book Regulations and Applications of Ethics in Business Practice by
Cover of the book Mechanical Ventilation in Patient with Respiratory Failure by
Cover of the book Copyright Law in the Digital World by
Cover of the book Iterative Learning Control for Systems with Iteration-Varying Trial Lengths by
Cover of the book Geo-Spatial Knowledge and Intelligence by
Cover of the book Proceedings of the Tenth International Conference on Management Science and Engineering Management by
Cover of the book Security in Computing and Communications by
Cover of the book Mathematical Analysis of Continuum Mechanics and Industrial Applications II by
Cover of the book Software Literacy by
Cover of the book Data Engineering and Intelligent Computing by
Cover of the book Multicultural Education in Glocal Perspectives by
Cover of the book The Development of Service Economy by
Cover of the book Emerging Technologies for Emerging Markets by
Cover of the book Applications of Cognitive Computing Systems and IBM Watson by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy